PMC:7324763 / 233-622
Annnotations
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T7","span":{"begin":46,"end":56},"obj":"SP_7"},{"id":"T8","span":{"begin":244,"end":248},"obj":"SP_10"},{"id":"T9","span":{"begin":250,"end":254},"obj":"SP_9"},{"id":"T10","span":{"begin":260,"end":268},"obj":"SP_7"},{"id":"T11","span":{"begin":307,"end":318},"obj":"CL:0000080"},{"id":"T12","span":{"begin":319,"end":326},"obj":"CL:0000623"},{"id":"T65641","span":{"begin":46,"end":56},"obj":"SP_7"},{"id":"T49418","span":{"begin":244,"end":248},"obj":"SP_10"},{"id":"T26865","span":{"begin":250,"end":254},"obj":"SP_9"},{"id":"T21591","span":{"begin":260,"end":268},"obj":"SP_7"},{"id":"T66187","span":{"begin":307,"end":318},"obj":"CL:0000080"},{"id":"T31308","span":{"begin":319,"end":326},"obj":"CL:0000623"}],"text":"ion, the contribution of NK cells in fighting SARS-CoV-2 has not yet been directly investigated. Insights into pathophysiology and therapeutic opportunities can therefore be inferred from studies assessing NK cell phenotype and function during SARS, MERS, and COVID-19. These studies suggest a reduction in circulating NK cell numbers and/or an exhausted phenotype following infection and "}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":25,"end":33},"obj":"Body_part"},{"id":"T5","span":{"begin":28,"end":33},"obj":"Body_part"},{"id":"T6","span":{"begin":206,"end":213},"obj":"Body_part"},{"id":"T7","span":{"begin":209,"end":213},"obj":"Body_part"},{"id":"T8","span":{"begin":319,"end":326},"obj":"Body_part"},{"id":"T9","span":{"begin":322,"end":326},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ion, the contribution of NK cells in fighting SARS-CoV-2 has not yet been directly investigated. Insights into pathophysiology and therapeutic opportunities can therefore be inferred from studies assessing NK cell phenotype and function during SARS, MERS, and COVID-19. These studies suggest a reduction in circulating NK cell numbers and/or an exhausted phenotype following infection and "}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":46,"end":54},"obj":"Disease"},{"id":"T5","span":{"begin":46,"end":50},"obj":"Disease"},{"id":"T6","span":{"begin":244,"end":248},"obj":"Disease"},{"id":"T7","span":{"begin":260,"end":268},"obj":"Disease"},{"id":"T8","span":{"begin":375,"end":384},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"ion, the contribution of NK cells in fighting SARS-CoV-2 has not yet been directly investigated. Insights into pathophysiology and therapeutic opportunities can therefore be inferred from studies assessing NK cell phenotype and function during SARS, MERS, and COVID-19. These studies suggest a reduction in circulating NK cell numbers and/or an exhausted phenotype following infection and "}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":25,"end":33},"obj":"http://purl.obolibrary.org/obo/CL_0000623"},{"id":"T4","span":{"begin":57,"end":60},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T5","span":{"begin":206,"end":213},"obj":"http://purl.obolibrary.org/obo/CL_0000623"},{"id":"T6","span":{"begin":292,"end":293},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T7","span":{"begin":319,"end":326},"obj":"http://purl.obolibrary.org/obo/CL_0000623"}],"text":"ion, the contribution of NK cells in fighting SARS-CoV-2 has not yet been directly investigated. Insights into pathophysiology and therapeutic opportunities can therefore be inferred from studies assessing NK cell phenotype and function during SARS, MERS, and COVID-19. These studies suggest a reduction in circulating NK cell numbers and/or an exhausted phenotype following infection and "}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"16","span":{"begin":46,"end":56},"obj":"Species"},{"id":"19","span":{"begin":260,"end":268},"obj":"Disease"},{"id":"20","span":{"begin":375,"end":384},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"Tax:2697049"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:C000657245"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ion, the contribution of NK cells in fighting SARS-CoV-2 has not yet been directly investigated. Insights into pathophysiology and therapeutic opportunities can therefore be inferred from studies assessing NK cell phenotype and function during SARS, MERS, and COVID-19. These studies suggest a reduction in circulating NK cell numbers and/or an exhausted phenotype following infection and "}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":97,"end":269},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ion, the contribution of NK cells in fighting SARS-CoV-2 has not yet been directly investigated. Insights into pathophysiology and therapeutic opportunities can therefore be inferred from studies assessing NK cell phenotype and function during SARS, MERS, and COVID-19. These studies suggest a reduction in circulating NK cell numbers and/or an exhausted phenotype following infection and "}